Company Filing History:
Years Active: 2010-2012
Title: Innovations by Svetoslav S Bratovanov
Introduction
Svetoslav S Bratovanov is a notable inventor based in Ancaster, Canada. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the preparation and purification of specific chemical compounds. With a total of 3 patents to his name, Bratovanov's work has implications for the development of important medicinal compounds.
Latest Patents
Bratovanov's latest patents include a process for the preparation and purification of cis-2-methylspiro(1,3-oxathiolane-5,3')quiniclidine hydrochloride. This innovative process involves treating a cis/trans mixture of isomers with an organic sulfonic acid to generate a less soluble acid addition salt that is enriched in the cis-isomer. The method allows for the enrichment of the cis-isomer through recrystallization or pulping using various organic solvents. Additionally, he has developed a process for the preparation of 2-methylspiro(1,3-oxathiolane-5,3')quiniclidine, known generally as Cevimeline, which is crucial for pharmaceutical applications.
Career Highlights
Bratovanov is currently employed at Apotex Pharmachem Inc., a leading company in the pharmaceutical industry. His work at Apotex has allowed him to focus on innovative processes that enhance the efficiency and effectiveness of drug development. His contributions have been instrumental in advancing the company's research and development efforts.
Collaborations
Bratovanov has collaborated with several talented individuals in his field, including Elena Bejan and Stephen E Horne. These collaborations have fostered a productive environment for innovation and have led to the successful development of new pharmaceutical processes.
Conclusion
Svetoslav S Bratovanov is a distinguished inventor whose work in pharmaceutical chemistry has led to significant advancements in drug preparation and purification. His innovative processes and collaborations continue to impact the industry positively.